APA

Gendre J. P., Mary J. Y., Florent C., Modigliani R., Colombel J. F., Soulé J. C., Galmiche J. P., Lerebours E., Descos L. & Viteau J. M. (19930226). Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). : Gastroenterology.

Chicago

Gendre J P, Mary J Y, Florent C, Modigliani R, Colombel J F, Soulé J C, Galmiche J P, Lerebours E, Descos L and Viteau J M. 19930226. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). : Gastroenterology.

Harvard

Gendre J. P., Mary J. Y., Florent C., Modigliani R., Colombel J. F., Soulé J. C., Galmiche J. P., Lerebours E., Descos L. and Viteau J. M. (19930226). Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). : Gastroenterology.

MLA

Gendre J P, Mary J Y, Florent C, Modigliani R, Colombel J F, Soulé J C, Galmiche J P, Lerebours E, Descos L and Viteau J M. Oral mesalamine (Pentasa) as maintenance treatment in Crohn's disease: a multicenter placebo-controlled study. The Groupe d'Etudes Thérapeutiques des Affections Inflammatoires Digestives (GETAID). : Gastroenterology. 19930226.